J B Chemicals & Pharmaceuticals has allotted 36,120 equity shares under ESOS on 18 December 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,55,12,608 equity shares of Re. 1 each to 15,55,48,728 equity shares of Re. 1 each.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 102,900 equity shares under ESOS on 06 December 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,54,09,708 equity shares of Re. 1 each to 15,55,12,608 equity shares of Re. 1 each. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 15.92% to Rs 174.57 crore in the quarter ended September 2024 as against Rs 150.59 crore during the previous quarter ended September 2023. Sales rose 13.48% to Rs 1000.62 crore in the quarter ended September 2024 as against Rs 881.74 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1000.62881.74 13 OPM %27.0427.62 - PBDT278.41240.83 16 PBT236.53208.66 13 NP174.57150.59 16 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,52,24,558 equity shares of Re. 1 each to 15,52,94,408 equity shares of Re. 1 each.Powered by Capital Market - Live News